• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer

Guttman, Buschner & Brooks

  • Home
  • Areas of Practice
    • High Impact Litigation
    • Whistleblower and False Claim Cases
    • Employment Litigation and Civil Rights – Employees
    • Employment Counseling and Litigation – Employers
    • Corporate Governance
  • Successes
  • Articles
  • Attorneys
    • Justin S. Brooks
    • Traci L. Buschner
    • Judge Nancy Gertner (Ret.)
    • Dan Guttman
    • Reuben A. Guttman
    • Brad Miller
    • Dr. Caroline Poplin
    • Elizabeth H. Shofner
    • Paul J. Zwier II
    • Aaron Welo
  • Amicus
  • Videos
  • Contact Us
    • Twitter
    • Facebook
    • LinkedIn

March 21, 2018 By Staff

Recovering $280 Million on the eve of trial in one of the most heavily litigated cases under the False Claims Act.

GBB recovered $280 million in a non-intervened False Claims Act case against Celgene Corporation on the eve of trial. The Complaint alleged that Celgene unlawfully marketed its drugs Thalomid and Revlimid, including for unsafe and ineffective uses, and subverted independent judgment of medical professionals through false and misleading promotion. The Complaint also alleged that Celgene paid kickbacks to medical professionals to prescribe and recommend Celgene’s drugs in violation of the Anti-Kickback Statute. The settlement is the second largest in a non-intervened case brought under the False Claims Act.

Primary Sidebar

Information

  • Where to Start
  • Whistleblower Information
  • Federal & State False Claims Acts
  • Protecting Whistleblowers

Footer

Guttman, Buschner & Brooks PLLC

Washington DC Office NEW!
Embassy Row District
1509 22nd Street, NW
Washington, D.C. 20037
Phone: 202-800-3001



Pennsylvania Office: New!
450 N. Narberth Avenue
Suite 102
Narberth, PA 19072
(610) 547-9556

Articles

Webinar: Non-state actors and global environmental governance in China

GBB News: Mass. General pays $14.6 million to settle whistle-blower suit over concurrent surgeries

Public-Private Litigation for Health

More Articles

Copyright © 2022 · Guttman, Buschner & Brooks PLLC
Disclaimer